溶瘤病毒
医学
临床试验
癌症
免疫系统
药物开发
免疫疗法
癌症免疫疗法
免疫学
药品
药理学
内科学
作者
Sean Lawler,Maria C. Speranza,Choi-Fong Cho,E. Antonio Chiocca
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2016-07-21
卷期号:3 (6): 841-841
被引量:563
标识
DOI:10.1001/jamaoncol.2016.2064
摘要
Oncolytic viruses are an active area of clinical research. The ability of these agents to harness antitumor immunity appears to be key for their success. Combinatorial studies with immune checkpoint blockade have started and the results are awaited with great interest.
科研通智能强力驱动
Strongly Powered by AbleSci AI